Compare MakeMyTrip Ltd (MMYT) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MakeMyTrip Ltd vs Novartis AG — how do they compare? MakeMyTrip Ltd trades at $56.43 (market cap $5.05B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 57.5× MakeMyTrip Ltd's market cap, and Novartis AG pays a 3.17% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| MMYT | NVS | |
|---|---|---|
Market Cap | $5.05B | $290.25B |
Sector | Technology | Health |
52-Week High | $103.21 | $168.62 |
52-Week Low | $36.30 | $113.50 |
Enterprise Value | $5.69B | $330.27B |
Dividend Yield | — | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
